fH1/DSP-0546LP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for fH1/DSP-0546LP, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: First-in-human Study to Assess the Safety, Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1/DSP-0546LP [Phase 1]